Nikita Shah sold $1.1M of Amneal Pharmaceuticals (AMRX)

Executed Aug 22 2025, disclosed Aug 25 2025, 3 days later.

Value, as filed

$1.1M

114,492 sh × $9.66

Executed

Aug 22 2025

the trade date, as filed

Disclosed

Aug 25 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

NS Nikita Shah Executive Vice President profile →

Nikita Shah (Executive Vice President) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $2.6M of AMRX (146,403 sh × $17.51, as filed), executed Aug 12.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Nikita Shah in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $2.6M
146,403 sh × $17.51
Exec Aug 12
Filed Aug 13 · 4:22 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $1.6M
131,856 sh × $11.92
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $666K
71,694 sh × $9.29
Exec Aug 14 2025
Filed Aug 15 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $452K
50,000 sh × $9.04
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $372K
49,140 sh × $7.58
Exec May 16 2025
Filed May 19 2025 · 5:30 PM ET